Skip to content
Screener

Dolby Laboratories, Inc. DLB Business Segments — Equity method investees’ net income

Similar metrics at other companies

LanzaTech Global, Inc. logo
LNZAReportable Segment — Loss from equity method investees, net
-$4.55M+30.4%
Evolent Health, Inc. logo
EVHReportable segment — Loss from equity method investees
-$41K-121%
Mama's Creations, Inc. logo
MAMAReportable Segment — Income from equity method investment
$0
BlackSky Technology logo
BKSYReportable Segment — Income on equity method investments
$0+100%
OppFi logo
OPFIReportable Segment — Income from equity method investment
$1.12M+4.1%
BridgeBio Pharma logo
BBIOReportable Segment — Income (Loss) from Equity Method Investments
-$18.28M-17.5%

Other financials

Income statement

See full
Revenue$395.6M+7.1%
Gross profit$350.9M+5.1%
Operating income$112.9M+4.8%
Net income$94.9M+3.4%
EPS (diluted)$0.99+5.3%

Balance sheet

See full
Cash & equivalents$673.8M-10.2%
Total debt$49.7M+22.9%
Total equity$2.6B+1.7%
Total assets$3.2B+0.6%

Cash flow

See full
Operating cash flow$92.5M-47.1%
CapEx$9.1M+31.4%
Free cash flow$83.4M-50.3%

Valuation

See full
Market cap$5.71B-17.7%
Enterprise value$5.08B-18.2%
P/E23.4×-2.8×
P/S4.2×-1.0×

Profitability

See full
Gross margin87.4%-1.5pp
Operating margin18.5%-2.0pp
Net margin17.9%-1.6pp
FCF margin22.1%-7.5pp

Returns & leverage

See full
Return on equity9.4%-0.9pp
Debt / equity0.0×
Current ratio-0.1×

Where this comes from

Reported directly by Dolby Laboratories, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromEquityMethodInvestments.

The source filing: Dolby Laboratories, Inc.’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:45 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q1 2026
Accession
0001308547-26-000010
Line itemFiscal Quarter Ended / March 27, 2026Fiscal Quarter Ended / March 28, 2025Fiscal Year-To-Date Ended / March 27, 2026Fiscal Year-To-Date Ended / March 28, 2025
Stock-based compensation30,70830,66467,91966,734
Amortization of acquisition-related intangibles9,71310,07819,58020,725
Interest (income)/expense, net(5,024)(3,559)(9,142)(6,205)
Equity method investees’ net income(3,118)(9,152)(8,394)(13,402)
Other income, net (1) (3)948(217)45925
Income tax expense24,24528,02442,16646,005
Net income including noncontrolling interest95,45492,226149,135160,296
Less: net income attributable to noncontrolling interest(539)(433)(893)(681)

ITEM 1. UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FAQ

What is Dolby Laboratories, Inc.'s business segments — equity method investees’ net income?
Dolby Laboratories, Inc. (DLB) reported business segments — equity method investees’ net income of -$3.12M in Q1 2026.
How has Dolby Laboratories, Inc.'s business segments — equity method investees’ net income changed year-over-year?
Dolby Laboratories, Inc.'s business segments — equity method investees’ net income increased by 65.9% year-over-year, from -$9.15M to -$3.12M.
What does business segments — equity method investees’ net income mean?
Reflects the segment's proportional share of the net earnings or losses from investments in entities where the company exercises significant influence but does not have full control. It provides insight into the performance of strategic partnerships and joint ventures.

Ask your AI about Dolby Laboratories, Inc.'s business segments — equity method investees’ net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude